CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (48,633)	$ (108,962)
Adjustments to reconcile net loss to net cash generated from / (used in) continuing operating activities:
Loss / (income) from discontinued operations, net of tax (Note 3)	8,064	(77)
Amortization of program rights	86,503	86,890
Depreciation and other amortization	18,270	17,225
Gain on disposal of fixed assets	(59)	(116)
Stock-based compensation (Note 17)	251	994
Change in fair value of derivatives (Note 12)	50	(104)
Foreign currency exchange loss, net	(460)	(49,882)
Net change in (net of effects of disposals of businesses):
Accounts receivable, net	25,589	39,148
Accounts payable and accrued liabilities	(11,709)	(7,625)
Program rights	(83,486)	(78,696)
Other assets	3,003	(1,769)
Accrued interest	(272)	(8,093)
Income taxes payable	(37)	(1,972)
Deferred revenue	18,024	16,047
Deferred taxes	(2,434)	(7,226)
VAT and other taxes payable	4,673	2,178
Net cash generated from / (used in) continuing operating activities	18,257	(2,276)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(8,982)	(10,230)
Disposal of property, plant and equipment	69	167
Net cash used in continuing investing activities	(8,913)	(10,063)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of senior debt	0	(20,467)
Debt transactions costs	(889)	(780)
Change in restricted cash	0	20,467
Proceeds from credit facilities	0	228
Payment of credit facilities and capital leases	(458)	(273)
Dividends paid to holders of noncontrolling interests	(46)	(113)
Net cash used in continuing financing activities	(1,393)	(938)
Net cash provided by discontinued operations - operating activities	348	713
Net cash used in discontinued operations - financing activities	(286)	(24)
Impact of exchange rate fluctuations on cash and cash equivalents	338	(5,309)
Net increase / (decrease) in cash and cash equivalents	8,351	(17,897)
CASH AND CASH EQUIVALENTS, beginning of period	104,035	139,663
CASH AND CASH EQUIVALENTS, end of period	112,386	121,766
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Accretion on Series B Convertible Redeemable Preferred Stock	$ 3,844	$ 0